Researchers from the University of Geneva and the University of Fribourg have developed a screening method that rapidly assesses and selects nanoparticles for their biocompatibility. The team’s work was published in the journal Nanoscale.
The researchers touted that they can determine if a nanoparticle will be compatible with the human body in less than a week – a process that traditionally takes months of research.
Get the full story at our sister site, Drug Delivery Business News.